Save
PED3005
Lecture 5
Save
Share
Learn
Content
Leaderboard
Learn
Created by
xAstros
Visit profile
Cards (22)
FMO3
Microsomal
enzyme —
FAD
prosthetic
group
Important in
oxidation
reactions at
nitrogen
,
sulphur
+
phosphorus
centres
5
diff forms —
FMO3
major
hepatic
isoform
FMO3
deficiency
Trimethylamine
(
TMA
) —
Unpleasant
smelling
compound
Breakdown
product
of no. of precursors (
L-cartinine
)
Normal —
conversion
to
TMA-N-oxide
(
TMAO
) by
FMO3
Lack
enzyme and suffer
fish
odour
syndrome
— ability to convert
TMA
→
TMAO
1 in 100
individuals
heterozygous
for this defect → some
impairment
in
TMA
metabolism
Fish odour syndrome - molecular basis
FMO3
gene sequenced in individuals with
fish
odour
syndrome
Most common mutation —
Pro153Leu
→ complete
loss
of
enzyme
activity
FMO3 common polymorphisms + mutations
N61S
→ Associated with lack of
TMA
oxidation
but
no
effect
on
methimazole
metabolism
E158K
/
E308G
→ compound polymorphism quite common —
DECREASED
ACTIVITY
(mild
FOS
in children)
Sulindac
metabolism
NSAID
—
chemoprevention
of
colon
cancer
Better outcome of those with
polymorphism
—
slower
metabolism
(
prodrug
activated by gut flora prior to
absorption
)
Paraoxonase
1
Arylesterase
→ hydrolyses
organophosphates
in
liver
+
serum
Referred to as
PON1
→ related
genes
(
PON2+3
) may have
diff
function
PON1
ass with
HDL
in serum + protect against
atherosclerosis
—
Hydrolyses
oxidised
LDL-associated
cholesterol
Paraoxonase 1 polymorphism
Arg192Gln
substitution
50
%
Europeans
—
low
activity of paraoxon
hydrolysis
in serum —
homozygous
for
Gln
10
%
North
Africans
RR
homozygotes
,
15.8
%
South
African
population
QQ
Relevance — use and choice of
pesticides
; however
range
of
enzyme
activities
Paraoxon
—
low
activity with
Gln
form
Phenylacetate
—
no
effect
Diazoxon
—
higher
activity w/
Gln
form
Some evidence for role of
PON1
in
atherosclerosis
/
CHD
, but
associations
not
strong
Relationship between
PON1
+
atherosclerosis
remain
controversial
Cholinesterase
Plasma
esterase
→
hydrolyses
succinylcholine
(
suxamethionium
)
5
% of population
heterozygous
for
poor
hydrolysis
alleles
Cholinesterase phenotyping
Most individuals with
deficient
hydrolysis
of
succinylcholine
show
normal
hydrolysis
of other substrates (
benzoylcholine
)
Can detect with
inhibition
pattern
of
benzoylcholine
hydrolysis
—
dibucaine
or
fluoride
Dibucaine
Measurement of
dibucaine
number —
Inhibition
of
benzoylcholine
hydrolysis
by
dibucaine
Atypical
—
less
inhibition than
wild
type
Genotypic basis of
cholinesterase
deficiency
Asp70Gly
—
atypical
form
Fluoride-sensitive
forms —
several
variants
Silent
forms —
no
enzyme
produced
(
frameshift
)
Other
forms
—
aa
substitutions
associated with
decreased
succinylcholine
hydrolysis
Relevance of
cholinesterase
deficiency
Prolonged
ventilation
after succinylcholine (apnoea)
Could
avoid
—
lower
doses
Screening not
usually
performed
Could
have sensitivity to
pesticides
—
unclear
Carboxylesterase
CES1
Oseltamavir
(
Tamiflu
)
Polymorphism of
functional
significance
Gly143Glu
—
low
activity (
4
% pop. freq.)
Asp260fs
—
no
activity
(
rare
)
Carboxylesterase
CES2
Aspirin
,
irinotecan
No
functionally
important
polymorphisms
described
as yet
Dihydropyrimidine
dehydrogenase
(
DYPD
)
Converts
uracil
→
thymine
→
dihydro
metabolites → further
metabolism
to
aas
5-Fluorouracil
(
5-FU
) —
anticancer
drug — metabolised by
DYPD
Rare
inborn
disorders
—
completely
lack
DYPD
→ suffer
epilepsy
+
mental
retardation
DYPD
reaction
Uracil
→
thymine
→
dihydro
metabolites
→ further
metabolism
to
aas
Molecular basis of
DYPD
deficiency
Recessive
trait
—
heterozygotes
(
2-3
%
Europeans
) show
lower
enzyme
levels
than normal
Most
common variant —
G→A
(intron
4
— position
1
) → skipping exon
14
+
truncated
protein
Heterozygotes
→
toxicity
if given
5-FU
Aldehyde dehydrogenase (
ALDH
)
Conversion of
acetylaldehyde
→
acetate
from
ethanol
consumption
ALDH1
—
Cytosolic
,
Higher
Km (=
100uM
)
ALDH2
—
Mitochondrial
,
Lower
Km (=
2-3uM
)
ALDH2
Deficiency
East
Asian
flush
+ suffer
nausea
following
ethanol
consumption
Due to
acetylaldehyde
accumulation
Glu487Lys
at
C-terminal
end of protein
Unstable
protein
produced
Dominant
inheritence
— consisting of
4
identical
subunits
Proteins
containing single ALDH2*2 are
catalytically
inactive
Consequences of ALDH2 deficiency